Docosatetraenoylethanolamide
Names
Preferred IUPAC name
(7Z ,10Z ,13Z ,16Z )-N -(2-Hydroxyethyl)docosa-7,10,13,16-tetraenamide
Other names
DEA
Identifiers
CAS Number
ChEMBL
ChemSpider
InChI=1S/C24H41NO2/c1-2-3-4-5-6-7-8-9-10-11-12-13-14-15-16-17-18-19-20-21-24(27)25-22-23-26/h6-7,9-10,12-13,15-16,26H,2-5,8,11,14,17-23H2,1H3,(H,25,27)/b7-6-,10-9-,13-12-,16-15-
Y Key: FMVHVRYFQIXOAF-DOFZRALJSA-N
Y
CCCCC/C=C\C/C=C\C/C=C\C/C=C\CCCCCC(=O)NCCO
Properties
Chemical formula
C24 H41 NO2
Molar mass
375.59 g/mol
Except where otherwise noted, data are given for materials in their standard state (at 25 °C [77 °F], 100 kPa).
Infobox references
Docosatetraenoylethanolamide (DEA) (Adrenoyl-ethanolamide) (Adrenoyl-EA) is an endogenous ethanolamide that has been shown to act on the cannabinoid (CB1 ) receptor .[ 1] DEA is similar in structure to anandamide (AEA, a recognized endogenous ligand for the CB1 receptor), containing docosatetraenoic acid in place of arachidonic acid . While DEA has been shown to bind to the CB1 receptor with similar potency and efficacy as AEA, its role as a cannabinergic neurotransmitter is not well understood.
Docosatetraenoylethanolamide (DEA) has been found in Tropaeolum tuberosum (Mashua) and Leonotis leonurus (Wild Dagga / Lion's Tail).[ 2]
References
^ Hanus, L.; Gopher, A.; Almog, S.; et al. (1993). "Two new unsaturated fatty acid ethanolamides in brain that bind to the cannabinoid receptor". J Med Chem . 36 (20): 3032– 3034. doi:10.1021/jm00072a026 . PMID 8411021 .
^ Hunter, E.; Stander, M.; Kossmann, J.; Chakraborty, S.; Prince, S.; Peters, S.; Loedolff, Bianke (2020). "Toward the identification of a phytocannabinoid-like compound in the flowers of a South African medicinal plant (Leonotis leonurus)" . BMC Research Notes . 13 (1): 522. doi:10.1186/s13104-020-05372-z . PMC 7653773 . PMID 33172494 .
Amino acid -derived
Lipid -derived
Endocannabinoids
2-AG
2-AGE (noladin ether)
2-ALPI
2-OG
AA-5-HT
Anandamide (AEA)
LPI
NADA
NAGly
OEA
Oleamide
PEA
RVD-Hpα
SEA
Virodhamine (O-AEA)
Neurosteroids
Nucleobase -derived
Vitamin -derived
Miscellaneous
Candidates
Acetaldehyde
Ammonia (NH3 )
Carbonyl sulfide (COS)
Nitrous oxide (N2 O)
Sulfur dioxide (SO2 )
Receptor (ligands )
CB1 Tooltip Cannabinoid receptor type 1
Agonists(abridged, full list)
2-AG
2-AGE (noladin ether)
11-Hydroxy-THC
α-Amyrin · β-Amyrin
AB-CHMINACA
AM-1172
AM-1220
AM-1221
AM-1235
AM-2201
AM-2232
Anandamide
Arvanil
AZ-11713908
Cannabinol
CB-13
CP 47,497
CP 55,940
Dimethylheptylpyran
ECG
EGCG
Epicatechin
Gallocatechol (gallocatechin)
Honokiol
HU-210
JWH-007
JWH-015
JWH-018
JWH-073
Kavain
L-759,633
Levonantradol
Menabitan
Nabilone
Nabitan
NADA
O-1812
Oleamide
Pravadoline
Serinolamide A
THC (dronabinol)
UR-144
WIN 55,212-2
Yangonin
Inverse agonists
AM-251
INV-202
Monlunabant
Rimonabant
Surinabant
Taranabant
TM-38837
Zevaquenabant
Antagonists
AM-6545
Cannabidiol
Cannabigerol
Drinabant
Falcarinol (carotatoxin)
Hemopressin
Ibipinabant
LY-320,135
MK-9470
NESS-0327
O-2050
Otenabant
PF-514273
PipISB
Rosonabant
Selonabant
THCV
VCHSR
Virodhamine
CB2 Tooltip Cannabinoid receptor type 2
Agonists
2-AG
2-AGE (noladin ether)
3,3'-Diindolylmethane
4-O-Methylhonokiol
α-Amyrin · β-Amyrin
A-796,260
A-834,735
A-836,339
AM-1172
AM-1221
AM-1235
AM-1241
AM-2232
Anandamide
AZ-11713908
Cannabinol
Caryophyllene
CB-13
CBS-0550
CP 55,940
GW-405,833 (L-768,242)
GW-842,166X
HU-308
JTE 7-31
JWH-007
JWH-015
JWH-018
JWH-73
JWH-133
L-759,633
L-759,656
Lenabasum (anabasum)
Magnolol
MDA-19
Nabitan
NADA
Olorinab (APD-371)
PF-03550096
S-444,823
SER-601
Serinolamide A
UR-144
Tedalinab
THC (dronabinol)
THCV
Tetrahydromagnolol
Virodhamine
Antagonists
4-O-Methylhonokiol
AM-630
BML-190
Cannabidiol
Honokiol
JTE-907
SR-144,528
WIN 54,461
WIN 56,098
NAGly (GPR18 )
Agonists
Abnormal cannabidiol
ACPA
AM251
Anandamide
Cannabidiol
NADGly
THC (dronabinol)
O-1602
Antagonists
GPR55
Agonists
2-AGE (noladin ether)
2-ALPI
Abnormal cannabidiol
AM-251
CID1011163
CID1252842
CID1792579
CP 55,940
GSK-494581A
Lysophosphatidylinositol
ML-184
ML-185
ML-186
O-1602
Oleoylethanolamide
Palmitoylethanolamide
THC (dronabinol)
Antagonists
Cannabidiol
CID-16020046
ML-191
ML-192
ML-193
O-1918
PSB-SB-487
PSB-SB-1202
PSB-SB-1203
Tetrahydromagnolol
GPR119
Agonists
2-Oleoylglycerol
Anandamide
APD668
AR-231,453
AS-1269574
MBX-2982
N-Oleoyldopamine
Oleoylethanolamide
Olvanil
PSN-375,963
PSN-632,408
Transporter(modulators )
eCBTs Tooltip Endocannabinoid transporter
Inhibitors: 5'-DMH-CBD
AM-404
AM-1172
Arachidonoyl serotonin
Arvanil
Cannabidiol
Guineensine
LY-2183240
O-2093
OMDM-2
Paracetamol (acetaminophen)
SB-FI-26
UCM-707
URB-597
VDM-11
WOBE490
WOBE491
WOBE492
Enzyme (modulators)
FAAH Tooltip Fatty acid amide hydrolase
Inhibitors: 4-Nonylphenylboronic acid
AACOCF3
AM-404
Arachidonoyl serotonin
BIA 10-2474
Biochanin A
Genistein
IDFP
JNJ-1661010
JNJ-42165279
JZL-195
Kaempferol
LY-2183240
MAFP
Palmitoylisopropylamide
Paracetamol (acetaminophen)
PF-3845
PF-750
Redafamdastat (JZP-150, PF-04457845)
SA-47
SA-57
TAK 21d
TC-F 2
UCM710
URB-597
MAGL
Inhibitors: ABX-1431
IDFP
JJKK 048
JW 642
JZL-184
JZL-195
JZP-361
KML 29
MAFP
MJN110
NAM
Pristimerin
URB-602
ABHD6
Inhibitors: JZP-169
JZP-430
KT182
KT185
KT195
KT203
LEI-106
ML294
ML295
ML296
UCM710
WWL-70
ABHD12
Inhibitors: Betulinic acid
Maslinic acid
MAFP
Oleanolic acid
Orlistat (tetrahydrolipstatin)
Ursolic acid
Others
Others: 2-PG (directly potentiates activity of 2-AG at CB1 receptor)
ARN-272 (FAAH-like anandamide transporter inhibitor)
See also
Receptor/signaling modulators
Cannabinoids (cannabinoids by structure)